Klose J, Schmitt A, Pernthaler J, Warschkow R, et al. Still proliferating CD44(+)/Ki67(+) tumor cells after neoadjuvant radiochemotherapy identify rectal cancer patients with poor survival. Eur J Surg Oncol 2021;47:2078-2086.
PMID: 33814238